1. Home
  2. Analysis
  3. Potassium
  4. Bidil

Potassium and Bidil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium (potassium) and Bidil (hydralazine hydrochloride; isosorbide dinitrate). Common drug interactions include cardiac failure congestive among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium and Bidil. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,147 Potassium users. Check the latest studies of Potassium.

What is Bidil?

Bidil has active ingredients of hydralazine hydrochloride; isosorbide dinitrate. eHealthMe is studying from 520 Bidil users. Check the latest studies of Bidil.

On Jul, 26, 2026

20 people who take Potassium and Bidil together, and have interactions are studied.

Potassium and Bidil drug interactions.

What are the common drug interactions of Potassium and Bidil, by gender? *:

female:

  1. Cardiac failure congestive
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Anaemia (lack of blood)
  4. Anxiety
  5. Asthma
  6. Basal ganglia infarction (disruption of the blood flow in the small blood vessels in the white matter of the cerebral cortex)
  7. Blood glucose increased
  8. Cardiac failure
  9. Cataract (clouding of the lens inside the eye)
  10. Chronic kidney disease

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Nervousness
  6. Photophobia (extreme sensitivity to light)
  7. Sinus congestion (blockage of sinus)
  8. Tinnitus (a ringing in the ears)
  9. Tremor (trembling or shaking movements in one or more parts of your body)
  10. Vertigo

What are the common drug interactions of Potassium and Bidil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal injury (kidney injury)

50-59:

  1. Cardiac failure congestive
  2. Chronic kidney disease
  3. Gout (uric acid crystals building up in the body)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Renal failure (kidney dysfunction)

60+:

  1. Basal ganglia infarction (disruption of the blood flow in the small blood vessels in the white matter of the cerebral cortex)
  2. Chronic kidney disease
  3. Thrombosis (formation of a blood clot inside a blood vessel)
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Hypotension (abnormally low blood pressure)
  6. Impaired gastric emptying
  7. Local swelling (swelling at the site of some application of substance or injury)
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Neuropathy peripheral (surface nerve damage)

What are the existing conditions these people have? *

  1. High Blood Pressure: 6 people, 30.00%
  2. Diabetes: 4 people, 20.00%
  3. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 15.00%
  4. Cardiac Disorder: 3 people, 15.00%
  5. Pain: 3 people, 15.00%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 15.00%
  7. High Blood Cholesterol: 3 people, 15.00%
  8. Cardiac Failure Congestive: 2 people, 10.00%
  9. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 10.00%
  10. Gout (uric acid crystals building up in the body): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium and Bidil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Potassium and Bidil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bidil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Potassium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bidil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on potassium and hydralazine hydrochloride; isosorbide dinitrate (the active ingredients of Potassium and Bidil, respectively), and Potassium and Bidil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.